miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.

Journal of Cellular Biochemistry
Shuyan LiuShengyun Lin


This study examined the underlying mechanism of miR-215-5p in multiple myeloma (MM) at the molecular level. miR-215-5p was upregulated in bone marrow specimens of patients with MM and MM cell lines through real-time polymerase chain reaction, and downregulation of miR-215-5p was related to poor survival of patients with MM. The results of Western blot assay showed that the PI3K/AKT/mTOR signaling pathway was activated in bone marrow specimens of patients with MM. miR-215-5p was found to negatively correlate with runt-related transcription factor 1 (RUNX1) expression in MM clinical bone marrow samples. Therefore, to test the probable mechanisms of the regulation of MM cell proliferation and apoptosis, a miR-215-5p mimics/inhibitors/negative control was transfected into MM cells. The targets of miR-215-5p were estimated using four bioinformatics databases (including miRDB, miRTarBase, Starbase, and Targetscan). Furthermore, enrichment analyses of gene ontology and Kyoto Encyclopedia of Genomes pathway were carried out at the Enrichr website. Cell viability was detected using the MTT method, while apoptosis and cell cycle were measured using flow cytometry. RUNX1, CDK2, CDC25B, cleaved-caspase-3, cleaved-PARP, p-PI3K, PI3K, p-AKT,...Continue Reading


Apr 23, 2009·International Journal of Cancer. Journal International Du Cancer·Andreas DollJaume Reventos
Oct 21, 2016·Biochimica Et Biophysica Acta·A Rasim BarutcuGary S Stein
Sep 20, 2017·Journal of Cellular Physiology·Jessica L PhillipsAdele F Holloway
Sep 20, 2017·Journal of Cellular Physiology·Jon RamseyC Matthew Kinsey
Jan 13, 2018·Leukemia & Lymphoma·Vijay Ramakrishnan, Shaji Kumar
Apr 18, 2018·International Journal of Molecular Sciences·Chaima El ArfaniEline Menu
Oct 24, 2018·Cancer Management and Research·Yan ChenLuo Gu
Apr 10, 2019·International Journal of Molecular Sciences·Jae Won YunWoong-Yang Park
Apr 10, 2019·Annals of Hematology·Cristina JoãoPaulo Lúcio
Apr 10, 2019·Expert Opinion on Investigational Drugs·Shirong LiKlaus Podar

❮ Previous
Next ❯


Feb 6, 2020·Cancers·Eugenio MorelliNicola Amodio
Aug 14, 2021·Technology in Cancer Research & Treatment·Wang LiLi Haisha

❮ Previous
Next ❯

Related Concepts

Related Feeds


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis